PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu, 210029, China.\', \'The First School of Clinical Medicine, Nanjing Medical University, 101 Longmian Avenue, Nanjing, Jiangsu 211166, China.\', \'School of Medical Imaging, Nanjing Medical University, 101 Longmian Avenue, Nanjing, Jiangsu 211166, China.\', \'Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu, 210029, China. Electronic address: zhoulei@njmu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1043-6618(20)31162-210.1016/j.phrs.2020.104854
?:hasPublicationType
?:journal
  • Pharmacological research
is ?:pmid of
?:pmid
?:pmid
  • 32360585
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.811
?:rankingScore_hIndex
  • 112
is ?:relation_isRelatedTo_publication of
?:title
  • Current targeted therapeutics against COVID-19: Based on first-line experience in China.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32360585>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32360585>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all